Akeso saw the highest growth of 119% in patent filings and 99% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Akeso’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Akeso has been focused on protecting inventions in European Patent Office(EPO) with four publications in Q4 2023

The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 14% filings and 0% grants. The World Intellectual Property Organization(WIPO), United States(US), European Patent Office(EPO), and Brazil(BR) patent Office are among the top ten patent offices where Akeso is filings its patents.

Amgen could be the strongest competitor for Akeso

Patents related to climate change and rare diseases lead Akeso's portfolio

Akeso has the highest number of patents in climate change followed by, rare diseases and health & wellness. For climate change, nearly 67% of patents were filed and no patents were granted in Q4 2023.

Bladder carcinoma related patents lead Akeso portfolio followed by breast cancer, and lung cancer

Akeso has highest number of patents in bladder carcinoma followed by breast cancer, lung cancer, colon cancer, and glioma.

For comprehensive analysis of Akeso's filings and grants, buy the databook here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.